Despite strong operational growth and reaffirmed guidance, the massive GAAP loss due to impairments may pressure sentiment. Monitor upcoming quarters for sustained EBITDA growth and cash flow trends. The recent $180M at-the-market offering adds dilution risk if fundamentals weaken.
Price Chart
Executive Summary
Tilray Brands reported Q3 fiscal 2026 results with net revenue of $206.7 million, up 11% year-over-year, driven by 73% growth in international cannabis revenue. Adjusted EBITDA rose 19% to $10.7 million, and the company reaffirmed full-year adjusted EBITDA guidance of $62–$72 million. However, GAAP net loss per share was $(0.24), a significant miss versus consensus of $0.27, due to one-time impairments and non-operating charges.
Key Financial Metrics
Key Facts
- Net revenue increased 11% YoY to $206.7 million, with international cannabis revenue up 73%.
- Adjusted EBITDA increased 19% to $10.7 million, beating prior-year $9.0 million.
- GAAP net loss per share was $(0.24), missing consensus of $0.27 by 188.9% due to $699.2 million in intangible asset impairments and $20 million in non-operating charges.
- Company reaffirmed full-year adjusted EBITDA guidance of $62–$72 million.
- Cash, restricted cash, and marketable securities totaled $264.8 million, with net cash position improving to $3.5 million.
Financial Impact
Revenue up 11% YoY to $206.7M, adjusted EBITDA up 19% to $10.7M, but GAAP net loss of $25.2M driven by $699.2M in impairments.
Risk Factors
- GAAP results distorted by large one-time impairments ($699.2M) and non-operating charges ($20M), masking underlying performance.
- $180M at-the-market offering filed six days prior raises concerns about capital needs despite strong cash balance.
- Guidance reaffirmed but lacks upward revision despite strong international growth, suggesting margin or macro headwinds.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001171843-26-002136 |
| Document: f8k_040126.htm | 0001171843-26-002136 |
| Document: 0001171843-26-002136-index-headers.html | 0001171843-26-002136 |
| Document: 0001171843-26-002136-index.html | 0001171843-26-002136 |
| Document: 0001171843-26-002136.txt | 0001171843-26-002136 |
| 8-K Data (Synthetic) | 0001171843-26-002136 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 8-K | $3.59 $3.54 | ▲ +1.39% | ▲ +1.99% | $2.72 (+24.23%) |
Sep 25, 2026 4w ago | Press Release | $4.13 | awaiting T+1 | — | $2.72 (−34.14%) |
Aug 10, 2026 11w ago | 8-K | $4.78 $4.68 | ▼ −2.09% | ▼ −2.34% | $2.72 (−43.10%) |
Jul 13, 2026 15w ago | Press Release | $4.38 | awaiting T+1 | — | $2.72 (−37.90%) |
Jun 30, 2026 16w ago | 8-K | $4.43 $4.62 | ▲ +4.29% | ▲ +4.42% | $2.72 (−38.60%) |
Jun 29, 2026 17w ago | Press Release | $4.49 $4.43 | ▼ −1.34% | ▼ −1.20% | $2.72 (−39.42%) |
Apr 15, 2026 27w ago | 424B5 | $6.95 $6.79 | ▲ +2.30% | ▲ +2.56% | $2.72 (+60.86%) |
Apr 15, 2026 27w ago | 8-K | $6.95 $6.79 | ▼ −2.30% | ▼ −2.56% | $2.72 (−60.86%) |
Apr 15, 2026 27w ago | Press Release | $6.95 $6.79 | ▼ −2.30% | ▼ −2.56% | $2.72 (−60.86%) |
Apr 1, 2026 29w ago | 8-K | $6.14 $6.55 | ▲ +6.68% | ▲ +6.60% | $2.72 (−55.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers